B
4.02
-0.10 (-2.43%)
| 前收盘价格 | 4.12 |
| 收盘价格 | 4.10 |
| 成交量 | 169,516 |
| 平均成交量 (3个月) | 533,411 |
| 市值 | 74,189,096 |
| 市盈率 (P/E TTM) | 50.25 |
| 价格/销量 (P/S) | 11.68 |
| 股市价格/股市净资产 (P/B) | 15.81 |
| 52周波幅 |
| 营业毛利率 | 20.58% |
| 营业利益率 (TTM) | 5.32% |
| 稀释每股收益 (EPS TTM) | 0.080 |
| 季度收入增长率 (YOY) | 5.80% |
| 季度盈利增长率 (YOY) | -36.70% |
| 总债务/股东权益 (D/E MRQ) | 75.55% |
| 流动比率 (MRQ) | 2.26 |
| 营业现金流 (OCF TTM) | 2.51 M |
| 杠杆自由现金流 (LFCF TTM) | 1.43 M |
| 资产报酬率 (ROA TTM) | 8.44% |
| 股东权益报酬率 (ROE TTM) | 31.77% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 看跌 |
| Medical Care Facilities (全球的) | 混合的 | 看跌 | |
| 股票 | Basel Medical Group Ltd Ordinar | - | - |
AIStockmoo 评分
-0.1
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.13 |
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 内部持股比例 | 67.81% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合